SEVERANCE AGREEMENT AND GENERAL RELEASESeverance Agreement and General Release • August 11th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations
This SEVERANCE AGREEMENT AND GENERAL RELEASE (the “Agreement”) is made and entered into by Chenyqua Baldwin (“Employee”) and Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”).
June 5, 2009Separation Letter Agreement and General Release • August 11th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • Massachusetts
This Separation Letter Agreement and General Release (the “Agreement”) sets forth and confirms the terms of the separation package that you are eligible to receive pursuant to Sections 4.4 and 5.5 of your Amended and Restated Employment Agreement dated November 6, 2007 as amended by the First Amendment to Amended and Restated Employment Agreement dated September 16, 2008 (together, the “Employment Agreement”) by and between Cornerstone Therapeutics Inc. (formerly known as Critical Therapeutics, Inc.) (the “Company”) and you (“you” or the “Employee”) as a result of the Company’s termination of your employment with the Company without “cause.” To receive the severance benefits, you must enter into a binding severance agreement drafted by and satisfactory to the Company. You will have twenty-one (21) days from your receipt of this Agreement to consider it and once you have signed this Agreement, you will have seven (7) days to revoke your acceptance as set forth in Paragraphs Nos. 8 and 1
